JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ordonez, L. A.
Right arrow Articles by Wurtman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ordonez, L. A.
Right arrow Articles by Wurtman, R. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 190, Issue 1, 187-191, 1974
Copyright © 1974 by American Society for Pharmacology and Experimental Therapeutics


SKELETAL MUSCLE: RESERVOIR FOR EXOGENOUS L-DOPA

L. A. Ordonez 1, M. Arbrus 1, S. Boyson 1, M. N. Goodman 1, N. B. Ruderman 1, and R. J. Wurtman 1

1 Massachusetts Institute of Technology, Department of Nutrition and Food Science, Cambridge, Massachusetts

In previous studies it has been shown that skeletal muscle concentrates exogenous L-dopa from the blood more effectively than most other tissues. The present study further examines the metabolism of L-dopa in muscle. At all times studied after L-dopa administration to rats, the concentrations of the drug were higher in muscle than in serum or brain. The total amounts of unmetabolized dopa present in muscle were increased by prior insulin administration or carbohydrate consumption; these treatments also increased brain dopa. Of the dopa-derived molecules present in various tissues after administration of the amino acid, muscle contained the largest unmetabolized fraction. This finding is compatible with in vitro evidence that muscle contains little catechol-O-methyltransferase or dopa decarboxylase activity and suggests that muscle does not metabolize dopa to a significant degree. Isolated perfused hindquarters taken from rats pretreated with L-dopa released the unmetabolized amino acid into the perfusate; this suggests that when L-dopa concentrations in skeletal muscle exceed those of serum, dopa may also be released into the circulation in vivo.

Submitted on August 14, 1973
Accepted on March 1, 1974




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
P. T. Mannisto and S. Kaakkola
Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors
Pharmacol. Rev., December 1, 1999; 51(4): 593 - 628.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics.